GCP Good Clinical Practice GFR Glomerular filtration rate Hgb Haemoglobin HR Hazard HRA/T Hazard ratio of ABI-007/carboplatin to Taxol/carboplatin ICH International Conference on Harmonisation IEC Independent Ethics Committee IRB Institutional Review Board ITT Intent-to-treat IV Intravenous IVR Interactive voice response KM Kaplan-Meier K-ras Kirsten rat sarcoma LD Longest diameter LLN Lower limit of normal Max Maximum MedDRA Medical Dictionary for Regulatory Activities Min Minimum MRI Magnetic resonance imaging MTD Maximum tolerated dose NA Not applicable NCI National Cancer Institute ND Not done NSCLC Non-small cell lung cancer ORR Overall response rate
GCP Good Clinical Practice GFR Glomerular filtration rate Hgb Haemoglobin HR Hazard HRA/T Hazard ratio of ABI-007/carboplatin to Taxol/carboplatin ICH International Conference on Harmonisation IEC Independent Ethics Committee IRB Institutional Review Board ITT Intent-to-treat IV Intravenous IVR Interactive voice response KM Kaplan-Meier K-ras Kirsten rat sarcoma LD Longest diameter LLN Lower limit of normal Max Maximum MedDRA Medical Dictionary for Regulatory Activities Min Minimum MRI Magnetic resonance imaging MTD Maximum tolerated dose NA Not applicable NCI National Cancer Institute ND Not done NSCLC Non-small cell lung cancer ORR Overall response rate